{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:46:39Z","timestamp":1782780399873,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-026-02306-x","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:03:19Z","timestamp":1777687399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-plex spatial protein profiling of skeletal muscle biopsies in inflammatory myopathies using the MACSima\u2122 imaging platform: A pilot study"],"prefix":"10.1186","volume":"14","author":[{"given":"Monica","family":"Sciacco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Velardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Bertolasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Ciscato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Mattinzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Ikehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo Pietro","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Zanotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"9","key":"2306_CR1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","volume":"17","author":"A Selva-O'Callaghan","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Pinal-Fernandez I, Trallero-Aragu\u00e1s E, Milisenda JC, Grau-Junyent JM, Mammen AL (2018) Classification and management of adult inflammatory myopathies. Lancet Neurol 17(9):816\u2013828. https:\/\/doi.org\/10.1016\/S1474-4422(18)30254-0","journal-title":"Lancet Neurol"},{"issue":"4","key":"2306_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMc1506827","volume":"373","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 373(4):393\u2013394. https:\/\/doi.org\/10.1056\/NEJMc1506827","journal-title":"N Engl J Med"},{"key":"2306_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/annrheumdis-2023-eular.3230","volume":"82","author":"R Aggarwal","year":"2023","unstructured":"Aggarwal R, Domyslawska I, Carreira P et al (2023) Pos1207 efficacy and safety of anti-INF-\u03b2-specific monoclonal antibody, pf-06823859, on myositis: Phase 2 study in patients with moderate-to-severe dermatomyositis. Ann Rheum Dis 82:936\u2013937","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2306_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1001\/jamadermatol.2023.4744","volume":"160","author":"KS Shaw","year":"2024","unstructured":"Shaw KS, Reusch DB, Castillo RL, Hashemi KB, Sundel R, Dedeoglu F, Vleugels RA (2024) Rapid improvement in recalcitrant cutaneous juvenile dermatomyositis with Anifrolumab treatment. JAMA Dermatol 160(2):237\u2013238. https:\/\/doi.org\/10.1001\/jamadermatol.2023.4744","journal-title":"JAMA Dermatol"},{"key":"2306_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1581323","volume":"16","author":"M Groener","year":"2025","unstructured":"Groener M, Paik JJ (2025) Emerging B and plasma cell-targeting immune therapies in idiopathic inflammatory myopathies. Front Immunol 16:1581323. https:\/\/doi.org\/10.3389\/fimmu.2025.1581323","journal-title":"Front Immunol"},{"issue":"8","key":"2306_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2308917","volume":"390","author":"F Muller","year":"2024","unstructured":"Muller F, Taubmann J, Bucci L, Wilhelm A, Bergamann C, Volkl S et al (2024) CD19 CAR-T-Cell therapy in autoimmune disease- a case series with follow-up. N Engl J Med 390(8):687\u2013700","journal-title":"N Engl J Med"},{"issue":"1","key":"2306_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-026-02076-9","volume":"26","author":"J Cheng","year":"2026","unstructured":"Cheng J, Zhang X, Fan Y, Zhang Z (2026) CAR-T therapy for autoimmune rheumatic diseases: Navigating clinical frontiers between breakthroughs and uncertainties. Clin Exp Med 26(1):177. https:\/\/doi.org\/10.1007\/s10238-026-02076-9","journal-title":"Clin Exp Med"},{"issue":"1","key":"2306_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-025-09047-0","volume":"68","author":"T Liu","year":"2025","unstructured":"Liu T, Chen B, Yin G, Xie Q (2025) Targeting B Cells for the treatment of idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 68(1):40. https:\/\/doi.org\/10.1007\/s12016-025-09047-0","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"2306_CR9","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/cont.0000000000001617","volume":"31","author":"MK Salajegheh","year":"2025","unstructured":"Salajegheh MK, Amato AA (2025) Idiopathic inflammatory myopathies. Continuum (Minneap Minn) 31(5):1385\u20131408. https:\/\/doi.org\/10.1212\/cont.0000000000001617","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"2306_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.55563\/clinexprheumatol\/2z01e0","volume":"44","author":"M Diomedi","year":"2026","unstructured":"Diomedi M, Fattorini F, Aliberti S, Bianchessi LM, Castellucci A, Schmidt J, Cavagna L, Carli L, Barsotti S (2026) Idiopathic inflammatory myopathies: one year in review 2025. Clin Exp Rheumatol 44(2):167\u2013177. https:\/\/doi.org\/10.55563\/clinexprheumatol\/2z01e0","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"2306_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073302","volume":"26","author":"EF Martins","year":"2025","unstructured":"Martins EF, Cappello CH, Shinjo SK, Appenzeller S, de Souza JM (2025) Idiopathic inflammatory myopathies: Recent evidence linking pathogenesis and clinical features. Int J Mol Sci 26(7):3302. https:\/\/doi.org\/10.3390\/ijms26073302","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2306_CR12","doi-asserted-by":"publisher","first-page":"34884","DOI":"10.1038\/s41598-025-17766-9","volume":"15","author":"Y Cao","year":"2025","unstructured":"Cao Y, Li W, He X, Liao M, Hu K, Wu S, Zhang X, Liao Q, Shen Z, Liang Z, Zheng C, Zhong Z, Jiang H, Huang Q, Zheng H (2025) Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathy. Sci Rep 15(1):34884. https:\/\/doi.org\/10.1038\/s41598-025-17766-9","journal-title":"Sci Rep"},{"issue":"18","key":"2306_CR13","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.3390\/jcm14186610","volume":"14","author":"J Yoon","year":"2025","unstructured":"Yoon J, Kim SW, Kim SH, Song JJ, Park YB, Park HJ, Shin HY, Park SH, Rhee Y (2025) Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy. J Clin Med 14(18):6610. https:\/\/doi.org\/10.3390\/jcm14186610","journal-title":"J Clin Med"},{"issue":"4","key":"2306_CR14","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s10067-026-07971-w","volume":"45","author":"K Treasure","year":"2026","unstructured":"Treasure K, Chugh R, Abbas H, Patel A (2026) Early detection and intervention in dermatomyositis: current evidence and clinical implications. Clin Rheumatol 45(4):2137\u20132148. https:\/\/doi.org\/10.1007\/s10067-026-07971-w","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2306_CR15","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.3390\/ijms25052742","volume":"25","author":"V Guglielmi","year":"2024","unstructured":"Guglielmi V, Cheli M, Tonin P, Vattemi G (2024) Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging. Int J Mol Sci 25(5):2742","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2306_CR16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/BOR.0000000000000832","volume":"33","author":"T Kurashige","year":"2021","unstructured":"Kurashige T (2021) Anti-HMGCR myopathy: clinical and histopathological features, and prognosis. Curr Opin Rheumatol 33(6):554\u2013562. https:\/\/doi.org\/10.1097\/BOR.0000000000000832","journal-title":"Curr Opin Rheumatol"},{"issue":"5 Suppl 1","key":"2306_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1590\/0004-282X-ANP-2022-S131","volume":"80","author":"AMS Silva","year":"2022","unstructured":"Silva AMS, Campos ED, Zanoteli E (2022) Inflammatory myopathies: an update for neurologists. Arq Neuropsiquiatr 80(5 Suppl 1):238\u2013248. https:\/\/doi.org\/10.1590\/0004-282X-ANP-2022-S131","journal-title":"Arq Neuropsiquiatr"},{"issue":"9","key":"2306_CR18","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1093\/brain\/awaf118","volume":"148","author":"F Kleefeld","year":"2025","unstructured":"Kleefeld F, Cross E, Lagos D, Walli S, Schoser B, Hentschel A, Ruck T, Nelke C, Hahn K, Hathazi D, Mammen AL, Casal-Dominguez M, Gut M, Gut IG, Heath S, Sch\u00e4nzer A, Goebel HH, Pinal-Fernandez I, Roos A, Preu\u00dfe C, Stenzel W, Horvath R (2025) Mitochondrial damage is associated with an early immune response in inclusion body myositis. Brain 148(9):3199\u20133214. https:\/\/doi.org\/10.1093\/brain\/awaf118","journal-title":"Brain"},{"issue":"1","key":"2306_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13672","volume":"16","author":"E Naddaf","year":"2025","unstructured":"Naddaf E, Nguyen TKO, Watzlawik JO, Gao H, Hou X, Fiesel FC, Mandrekar J, Kokesh E, Harmsen WS, Lanza IR, Springer W, Trushina E (2025) NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis. J Cachexia Sarcopenia Muscle 16(1):e13672. https:\/\/doi.org\/10.1002\/jcsm.13672","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"7","key":"2306_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s43587-024-00645-9","volume":"4","author":"S Wischnewski","year":"2024","unstructured":"Wischnewski S, Th\u00e4wel T, Ikenaga C, Kocharyan A, Lerma-Martin C, Zulji A, Rausch HW, Brenner D, Thomas L, Kutza M, Wick B, Trobisch T, Preusse C, Haeussler M, Leipe J, Ludolph A, Rosenbohm A, Hoke A, Platten M, Weishaupt JH, Sommer CJ, Stenzel W, Lloyd TE, Schirmer L (2024) Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositis. Nat Aging 4(7):969\u2013983. https:\/\/doi.org\/10.1038\/s43587-024-00645-9","journal-title":"Nat Aging"},{"issue":"11","key":"2306_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103644","volume":"23","author":"S Brady","year":"2024","unstructured":"Brady S, Poulton J, Muller S (2024) Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy. Autoimmun Rev 23(11):103644. https:\/\/doi.org\/10.1016\/j.autrev.2024.103644","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2306_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-026-02243-9","volume":"14","author":"F Kleefeld","year":"2026","unstructured":"Kleefeld F, Schroeter CB, Abdennebi D, Dobelmann V, Walli S, Roos A, Distler U, Tenzer S, Bopp T, Quint P, Schmitt LI, Leo M, Hagenacker T, Pinal-Fernandez I, Casal-Dominguez M, Mammen AL, Preu\u00dfe C, Maggi L, Mensch A, Meuth SG, Stenzel W, Ruck T, Nelke C (2026) Proteomic profiles in inclusion body myositis and polymyositis with mitochondrial pathology. Acta Neuropathol Commun 14(1):49. https:\/\/doi.org\/10.1186\/s40478-026-02243-9","journal-title":"Acta Neuropathol Commun"},{"issue":"1-2","key":"2306_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2013.08.007","volume":"334","author":"ML Kosmidis","year":"2013","unstructured":"Kosmidis ML, Alexopoulos H, Tzioufas AG, Dalakas MC (2013) The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot study. J Neurol Sci 334(1\u20132):123\u2013125. https:\/\/doi.org\/10.1016\/j.jns.2013.08.007","journal-title":"J Neurol Sci"},{"issue":"10","key":"2306_CR24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S1474-4422(23)00275-2","volume":"22","author":"PM Machado","year":"2023","unstructured":"Machado PM, McDermott MP, Blaettler T, Sundgreen C, Amato AA, Ciafaloni E, Freimer M, Gibson SB, Jones SM, Levine TD, Lloyd TE, Mozaffar T, Shaibani AI, Wicklund M, Rosholm A, Carstensen TD, Bonefeld K, J\u00f8rgensen AN, Phonekeo K, Heim AJ, Herbelin L, Barohn RJ, Hanna MG, Dimachkie MM, Arimoclomol in IBM Investigator Team of the Neuromuscular Study Group (2023) Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 22(10):900\u2013911. https:\/\/doi.org\/10.1016\/S1474-4422(23)00275-2","journal-title":"Lancet Neurol"},{"issue":"1","key":"2306_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-021-00279-0","volume":"11","author":"M Murgia","year":"2021","unstructured":"Murgia M, Nogara L, Baraldo M, Reggiani C, Mann M, Schiaffino S (2021) Protein profile of fiber types in human skeletal muscle: a single-fiber proteomics study. Skeletal Muscle 11(1):24. https:\/\/doi.org\/10.1186\/s13395-021-00279-0","journal-title":"Skeletal Muscle"},{"issue":"7","key":"2306_CR26","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1021\/pr800873q","volume":"8","author":"KC Parker","year":"2009","unstructured":"Parker KC, Walsh RJ, Salajegheh M, Amato AA, Krastins B, Sarracino DA, Greenberg SA (2009) Characterization of human skeletal muscle biopsy samples using shotgun proteomics. J Proteome Res 8(7):3265\u20133277. https:\/\/doi.org\/10.1021\/pr800873q","journal-title":"J Proteome Res"},{"issue":"9","key":"2306_CR27","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1021\/jasms.3c00072","volume":"34","author":"A Momenzadeh","year":"2023","unstructured":"Momenzadeh A, Jiang Y, Kreimer S, Teigen LE, Zepeda CS, Haghani A, Mastali M, Song Y, Hutton A, Parker SJ, Van Eyk JE, Sundberg CW, Meyer JG (2023) A complete workflow for high throughput human single skeletal muscle fiber proteomics. J Am Soc Mass Spectrom 34(9):1858\u20131867. https:\/\/doi.org\/10.1021\/jasms.3c00072","journal-title":"J Am Soc Mass Spectrom"},{"issue":"1","key":"2306_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05841-4","volume":"12","author":"A Kinkhabwala","year":"2022","unstructured":"Kinkhabwala A, Herbel C, Pankratz J, Yushchenko DA, R\u00fcberg S, Praveen P, Rei\u00df S, Rodriguez FC, Sch\u00e4fer D, Kollet J, Dittmer V, Martinez-Osuna M, Minnerup L, Reinhard C, Dzionek A, Rockel TD, Borbe S, B\u00fcscher M, Krieg J, Nederlof M, Jungblut M, Eckardt D, Hardt O, Dose C, Schumann E, Peters RP, Miltenyi S, Schmitz J, M\u00fcller W, Bosio A (2022) MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors. Sci Rep 12(1):1911. https:\/\/doi.org\/10.1038\/s41598-022-05841-4","journal-title":"Sci Rep"},{"key":"2306_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1383932","volume":"15","author":"S Scheuermann","year":"2024","unstructured":"Scheuermann S, Kristmann B, Engelmann F, Nuernbergk A, Scheuermann D, Koloseus M, Abed T, Solass W, Seitz CM (2024) Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging. Front Immunol 15:1383932. https:\/\/doi.org\/10.3389\/fimmu.2024.1383932","journal-title":"Front Immunol"},{"issue":"2","key":"2306_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/eji.70157","volume":"56","author":"ISM Molina","year":"2026","unstructured":"Molina ISM, Okkenhaug H, Walker S, Linterman M, Marcial-Ju\u00e1rez E (2026) Spatial profiling of germinal centers in mouse secondary lymphoid organs using MACSima imaging cyclic staining technology. Eur J Immunol 56(2):e70157. https:\/\/doi.org\/10.1002\/eji.70157","journal-title":"Eur J Immunol"},{"issue":"D1","key":"2306_CR31","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkab835","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, Jensen LJ, von Mering C (2021) The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 49(D1):D605\u2013D612. https:\/\/doi.org\/10.1093\/nar\/gkab835","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2306_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284\u2013287","journal-title":"OMICS"},{"issue":"8","key":"2306_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/ncpneuro0261","volume":"2","author":"MC Dalakas","year":"2006","unstructured":"Dalakas MC (2006) Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2(8):437\u2013447. https:\/\/doi.org\/10.1038\/ncpneuro0261","journal-title":"Nat Clin Pract Neurol"},{"issue":"6","key":"2306_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/acn3.419","volume":"4","author":"CW Keller","year":"2017","unstructured":"Keller CW, Schmidt J, L\u00fcnemann JD (2017) Immune and myodegenerative pathomechanisms in inclusion body myositis. Ann Clin Transl Neurol 4(6):422\u2013445. https:\/\/doi.org\/10.1002\/acn3.419","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"2306_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01605-9","volume":"9","author":"S Gandolfi","year":"2023","unstructured":"Gandolfi S, Pileyre B, Drouot L, Dubus I, Auquit-Auckbur I, Martinet J (2023) Stromal vascular fraction in the treatment of myositis. Cell Death Discov 9(1):346. https:\/\/doi.org\/10.1038\/s41420-023-01605-9","journal-title":"Cell Death Discov"},{"key":"2306_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf346","author":"RA Kirou","year":"2025","unstructured":"Kirou RA, Pinal-Fernandez I, Casal-Dominguez M, Pak K, Preusse C, Dari D, Del Orso S, Naz F, Islam S, Gutierrez-Cruz G, Naddaf E, Liewluck T, Stenzel W, Selva-O\u2019Callaghan A, Milisenda JC, Mammen AL (2025) Distinct cytokine and cytokine receptor expression patterns characterize different forms of myositis. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keaf346","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"2306_CR37","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ana.20464","volume":"57","author":"SA Greenberg","year":"2005","unstructured":"Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA (2005) Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57(5):664\u2013678. https:\/\/doi.org\/10.1002\/ana.20464","journal-title":"Ann Neurol"},{"issue":"5","key":"2306_CR38","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1083\/jcb.200212031","volume":"161","author":"Y Takeda","year":"2003","unstructured":"Takeda Y, Tachibana I, Miyado K, Kobayashi M, Miyazaki T, Funakoshi T, Kimura H, Yamane H, Saito Y, Goto H, Yoneda T, Yoshida M, Kumagai T, Osaki T, Hayashi S, Kawase I, Mekada E (2003) Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes. J Cell Biol 161(5):945\u2013956. https:\/\/doi.org\/10.1083\/jcb.200212031","journal-title":"J Cell Biol"},{"key":"2306_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00863","volume":"9","author":"R Reyes","year":"2018","unstructured":"Reyes R, Carde\u00f1es B, Machado-Pineda Y, Caba\u00f1as C (2018) Tetraspanin CD9: a key regulator of cell adhesion in the immune system. Front Immunol 9:863. https:\/\/doi.org\/10.3389\/fimmu.2018.00863","journal-title":"Front Immunol"},{"issue":"6184","key":"2306_CR40","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/334701a0","volume":"334","author":"M Moos","year":"1988","unstructured":"Moos M, Tacke R, Scherer H, Teplow D, Fr\u00fch K, Schachner M (1988) Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature 334(6184):701\u2013703. https:\/\/doi.org\/10.1038\/334701a0","journal-title":"Nature"},{"issue":"15","key":"2306_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512531","volume":"24","author":"G Loers","year":"2023","unstructured":"Loers G, Kleene R, Granato V, Bork U, Schachner M (2023) Interaction of L1CAM with LC3 is required for L1-dependent neurite outgrowth and neuronal survival. Int J Mol Sci 24(15):12531. https:\/\/doi.org\/10.3390\/ijms241512531","journal-title":"Int J Mol Sci"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02306-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02306-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02306-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:29:42Z","timestamp":1782779382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02306-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2306"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02306-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of the \u201cIRCCS Ca\u2019 Granda Foundation Ospedale Maggiore Policlinico, Italy\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"Written informed consent has been obtained from both patient and controls to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent Statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"138"}}